Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Royalty Pharma plc | EVP & Vice Chairman | Class A Ordinary Shares | 370K | $11.2M | $30.23 | May 13, 2024 | By SCH Investment Partners LLC |
Royalty Pharma plc | EVP & Vice Chairman | LP interests in RPI US Partners 2019, LP | 541 | May 13, 2024 | By SCH Investment Partners LLC | ||
ACCELERON PHARMA INC | Director | Common Stock | 0 | $29.37 | Nov 19, 2021 | Direct | |
ACCELERON PHARMA INC | Director | Option to Purchase Common Stock | 0 | Nov 19, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RPRX | Royalty Pharma plc | May 13, 2024 | 2 | $0 | 4 | May 16, 2024 | EVP & Vice Chairman |
XLRN | ACCELERON PHARMA INC | Nov 19, 2021 | 3 | $0 | 4 | Nov 22, 2021 | Director |